Service de Réanimation Médicale, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg 67000, France.
Service de Chirurgie Hépatobiliaire et Transplantation, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg 67000, France.
World J Gastroenterol. 2018 Dec 14;24(46):5203-5214. doi: 10.3748/wjg.v24.i46.5203.
Liver transplantation for critically ill cirrhotic patients with acute deterioration of liver function associated with extrahepatic organ failures is controversial. While transplantation has been shown to be beneficial on an individual basis, the potentially poorer post-transplant outcome of these patients taken as a group can be held as an argument against allocating livers to them. Although this issue concerns only a minority of liver transplants, it calls into question the very heart of the allocation paradigms in place. Indeed, most allocation algorithms have been centered on prioritizing the sickest patients by using the model for end-stage liver disease score. This has led to allocating increasing numbers of livers to increasingly critically ill patients without setting objective or consensual limits on how sick patients can be when they receive an organ. Today, finding robust criteria to deem certain cirrhotic patients too sick to be transplanted seems urgent in order to ensure the fairness of our organ allocation protocols. This review starts by fleshing out the argument that finding such criteria is essential. It examines five types of difficulties that have hindered the progress of recent literature on this issue and identifies various strategies that could be followed to move forward on this topic, taking into account the recent discussion on acute on chronic liver failure. We move on to review the literature along four axes that could guide clinicians in their decision-making process regarding transplantation of critically ill cirrhotic patients.
肝移植用于肝功能衰竭合并肝外器官衰竭的危重肝硬化患者存在争议。虽然移植在个体基础上显示出有益,但这些患者作为一个群体的移植后预后较差,可以作为反对为他们分配肝脏的理由。尽管这个问题只涉及少数肝移植,但它质疑了现有的分配模式的核心。事实上,大多数分配算法都集中在通过终末期肝病模型评分来优先考虑最病重的患者。这导致越来越多的肝脏被分配给越来越危重的患者,而没有为患者接受器官时的病情设定客观或共识的限制。今天,为了确保我们的器官分配方案的公平性,找到强有力的标准来判断某些肝硬化患者是否病得太重而无法移植似乎迫在眉睫。这篇综述首先阐述了找到这些标准的必要性。它检查了阻碍最近关于这个问题的文献进展的五种类型的困难,并确定了可以遵循的各种策略,以考虑到关于慢性肝衰竭的最近讨论,在这个问题上取得进展。我们接着沿着四个轴回顾文献,这可以指导临床医生在决定对危重肝硬化患者进行移植时的决策过程。